| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute hemodynamic effects of terazosin in hypertensive and normotensive patients
|
Strom, Joel A.
|
|
1991
|
122 |
3P2 |
p. 892-900
9 p.
|
artikel
|
| 2 |
Antihypertensive dose-response relationships: Studies with the selective α 1-blocking agent terazosin
|
Weber, Michael A.
|
|
1991
|
122 |
3P2 |
p. 905-910
6 p.
|
artikel
|
| 3 |
Antihypertensive therapy: Taking lipids into consideration
|
Grimm Jr, Richard H.
|
|
1991
|
122 |
3P2 |
p. 910-918
9 p.
|
artikel
|
| 4 |
Clinical implications of pathophysiologic changes in the midlife hypertensive patient
|
Julius, Stevo
|
|
1991
|
122 |
3P2 |
p. 886-891
6 p.
|
artikel
|
| 5 |
Combination antihypertensive therapy with terazosin and other antihypertensive agents: Results of clinical trials
|
Pool, James L.
|
|
1991
|
122 |
3P2 |
p. 926-931
6 p.
|
artikel
|
| 6 |
Introduction
|
Weber, Michael A.
|
|
1991
|
122 |
3P2 |
p. 885-886
2 p.
|
artikel
|
| 7 |
Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy
|
Sowers, James R.
|
|
1991
|
122 |
3P2 |
p. 932-935
4 p.
|
artikel
|
| 8 |
Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents
|
Cohen, Jerome D.
|
|
1991
|
122 |
3P2 |
p. 919-925
7 p.
|
artikel
|
| 9 |
Terazosin: Pharmacokinetics and the effect of age and dose on the incidence of adverse events
|
Somberg, John C.
|
|
1991
|
122 |
3P2 |
p. 901-905
5 p.
|
artikel
|
| 10 |
The safety and efficacy of terazosin in the treatment of essential hypertension in blacks
|
Saunders, Elijah
|
|
1991
|
122 |
3P2 |
p. 936-942
7 p.
|
artikel
|
Tijdschrift beschrijving